In this edition, we share a perspective that captures a profound shift occurring inside Market Access and across the broader pharma landscape. As access teams move into earlier stages of development and take on greater strategic responsibility, the expectations placed on leaders continue to expand—demanding not only analytical strength but a deeper understanding of how value is communicated and understood.
Luise Ingemann, Co-founder of Value Republic, offers a compelling examination of this evolution. Her analysis challenges the long-standing belief that data alone determines access outcomes, and instead argues that influence, clarity, and the ability to build coherent narratives are becoming essential capabilities for today’s leaders. In an environment shaped by political pressures, public scrutiny, and rapidly shifting policy priorities, her viewpoint resonates strongly with the realities many teams face today.
This article invites us to reconsider how evidence is used, how decisions are shaped, and how leaders can more effectively connect clinical, economic, and human perspectives. If you have an article you would like to share, please contact me.
Thank you for reading.
